Banères Jean-Louis, Mesnier Danielle, Martin Aimée, Joubert Lara, Dumuis Aline, Bockaert Joel
UMR CNRS 5074, Chimie Biomoléculaire et Interactions Biologiques, Faculté de Pharmacie, 15 Avenue Ch. Flahault, 34093 Montpellier Cedex 05, France.
J Biol Chem. 2005 May 27;280(21):20253-60. doi: 10.1074/jbc.M412009200. Epub 2005 Mar 17.
Serotonin 5-HT(4(a)) receptor, a G-protein-coupled receptor (GPCR), was produced as a functional isolated protein using Escherichia coli as an expression system. The isolated receptor was characterized at the molecular level by circular dichroism (CD) and steady-state fluorescence. A specific change in the near-UV CD band associated with the GPCR disulfide bond connecting the third transmembrane domain to the second extracellular loop (e2) was observed upon agonist binding to the purified receptor. This is a direct experimental evidence for a change in the conformation of the e2 loop upon receptor activation. Different variations were obtained depending whether the ligand was an agonist (partial or full) or an inverse agonist. In contrast, antagonist binding did not induce any variation. These observations provide a first direct evidence for the fact that free (or antagonist-occupied), active (partial- or full agonist-occupied) and silent (inverse agonist-occupied) states of the receptor involve different arrangements of the e2 loop. Finally, ligand-induced changes in the fluorescence emission profile of the purified receptor confirmed that the partial agonist stabilized a single, well-defined, conformational state and not a mixture of different states. This result is of particular interest in a pharmacological perspective since it directly demonstrates that the efficacy of a drug is likely due to the stabilization of a ligand-specific state rather than selection of a mixture of different conformational states of the receptor.
血清素5-HT(4(a))受体是一种G蛋白偶联受体(GPCR),它通过使用大肠杆菌作为表达系统被制备为一种功能性分离蛋白。通过圆二色性(CD)和稳态荧光在分子水平上对分离出的受体进行了表征。当激动剂与纯化的受体结合时,观察到与连接第三个跨膜结构域和第二个细胞外环(e2)的GPCR二硫键相关的近紫外CD带发生了特定变化。这是受体激活时e2环构象变化的直接实验证据。根据配体是激动剂(部分或完全)还是反向激动剂,会获得不同的变化。相比之下,拮抗剂结合不会引起任何变化。这些观察结果首次直接证明了受体的游离(或拮抗剂占据)、活性(部分或完全激动剂占据)和沉默(反向激动剂占据)状态涉及e2环的不同排列。最后,纯化受体的荧光发射谱中配体诱导的变化证实,部分激动剂稳定了单一的、明确的构象状态,而不是不同状态的混合物。从药理学角度来看,这一结果特别有趣,因为它直接表明药物的疗效可能是由于配体特异性状态的稳定,而不是受体不同构象状态混合物的选择。